Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ion TabarnafiledCriticalIon Tabarna
Priority to MDA20000145ApriorityCriticalpatent/MD1664G2/en
Publication of MD1664F1publicationCriticalpatent/MD1664F1/en
Publication of MD1664G2publicationCriticalpatent/MD1664G2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention refers to medicine, namely to gastrology and is provided for ulcer antirecidivation treatment. The method consists in the continuous daily administration of the antacids, for example, of aluminium and magnesium hydroxides, during 2-3 years in the therapeutic effective semi-dose.The result of the invention consists in the stable and longevous ulcer remission.Claims: 1
MDA20000145A2000-08-292000-08-29Method of ulcer recidivation prophylaxis
MD1664G2
(en)
The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura